SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: (S,E)-6-(2-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)vinyl)-4-hydroxy-5,6-dihydro-2H-pyran-2-one monosodium salt
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: O=C1C=C([O-])C[C@@H](/C=C/C(N2C(C)C)=C(C3=CC=C(F)C=C3)C4=C2C=CC=C4)O1.[Na+]
Fluvastatin lactone S-Isomer is chemically (S,E)-6-(2-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)vinyl)-4-hydroxy-5,6-dihydro-2H-pyran-2-one monosodium salt. Fluvastatin lactone S-Isomer is supplied with detailed characterization data compliant with regulatory guideline. Fluvastatin lactone S-Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluvastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Improvement of development and validation of an RP-HPLC method for the fluvastatin sodium using QbD approach and its application to forced degradation studies
By Balasaheb, Dhamdhere Rupali; Vijayalakshmi, A.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2020), 11(4), 6938-6948
Method development and validation of Fluvastatin by RP-HPLC
By Monika, Mallepally; Preethi, Ch. Sai; Aruna Rekha, D.; Pandey, Durgesh; Madhuri, G.
From World Journal of Pharmacy and Pharmaceutical Sciences (2020), 9(5), 1342-1351
Development and Validation of Stability-Indicating HPLC Methods for Quantitative Determination of Pravastatin, Fluvastatin, Atorvastatin, and Rosuvastatin in Pharmaceuticals
By Gomes, Fabio Pereira; Garcia, Pedro Lopez; Alves, Joao Marcel Porto; Singh, Anil Kumar; Kedor-Hackmann, Erika Rosa Maria; Santoro, Maria Ines Rocha Miritello
From Analytical Letters (2009), 42(12), 1784-1804